Yang Daoke Academician Professor, Chief Physician
Yang Daoke Academician Professor, Chief Physician
Fellow of the Royal Society of Medicine, UK
International Society of Clinical Oncology (ISCO) Vice Chairman.
Founding President of the Radiation Oncology Physician Branch, Chinese Medical Doctor Association
Chairman of the Tumor Hyperthermia Committee, China Anti-Cancer Association
Vice Chairman of the Integrative Oncology Committee, Chinese Medical Doctor Association
Visiting Professor at Philadelphia Cancer Center, USA
Deputy Director of the Academic Department, National Health Commission Capacity Building and Continuing Education Center
Specially appointed expert for radiation oncology at the Medical Science and Technology Development Center of the National Health and Family Planning Commission.
Expert Profile: Engaged in clinical and scientific research in oncology for30years, he has published40academic papers, of whichSCIwere indexed by SCI10papers. He has received ... achievement awards from the Provincial Education Commission and the Science and Technology Department,5and has presided over ... provincial and ministerial-level research projects,5and guided ... National Natural Science Foundation projects.2He is proficient in various cutting-edge new technologies and methods for cancer treatment. Clinically, he excels in individualized comprehensive anti-tumor treatment centered on radiotherapy and hyperthermia, especially in head and neck tumors, lung cancer, esophageal cancer, cervical cancer, colorectal cancer, nasal-typeNK/Tlymphoma, malignant pleural effusion and ascites, and various othermalignant tumorconditions, with extensive clinical experience in diagnosis and treatment.
Professional Expertise: One of the earliest pioneers of comprehensive cancer treatment in China. He excels in individualized comprehensive anti-tumor treatment centered on radiotherapy and hyperthermia, especially for head and neck tumors, lung cancer, esophageal cancer, cervical cancer, colorectal cancer, nasal-typeNKTlymphoma, malignant pleural effusion and ascites, and various othermalignant tumorconditions. He strictly follows national cancer treatment guidelines and has achieved favorable therapeutic outcomes.